A panel of biologically contained orthoebolaviruses for the screening of broad-spectrum antivirals
Jens Verlinden, Joren Stroobants, Jesus Sacramento Nonay, Charlotte Willems, Kato Govaerts, Bram Van Holm, Winston Chiu, Joost Schepers, Thibault Francken, Viktor Lemmens, Kurt Vermeire, Bert Vanmechelen
This study develops a biosafety level 2-compatible panel of orthoebolaviruses for screening broad-spectrum antivirals, identifying both broad-acting and virus-specific candidates.
bioRxiv · Jul 31, 2026 · PreprintMicrobiology